Literature DB >> 33722672

Inhibition of miR-103-3p Preserves Neurovascular Integrity Through Caveolin-1 in Experimental Subarachnoid Hemorrhage.

Liumin Wang1, Ying Zhao2, Shucheng Gang1, Tongchao Geng1, Mingquan Li1, Lili Xu2, Xiaohao Zhang2, Ling Liu2, Yi Xie3, Ruidong Ye4, Xinfeng Liu2.   

Abstract

Caveolin-1 (Cav-1) is a constitutive structural protein of caveolae in the plasma membrane. It plays an important role in maintaining blood brain barrier (BBB) integrity. In this study, we identified that miR-103-3p, a hypoxia-responsive miRNA, could interact with Cav-1. In endothelial cells, miR-103-3p mimic diminished the expression of Cav-1 and tight junction proteins, which were rescued by the inhibition of miR-103-3p. We found a substantial increase of miR-103-3p and decease of Cav-1 in the rat subarachnoid hemorrhage (SAH) model. Pre-SAH intracerebroventricularly injection of miR-103-3p antagomir relieved Cav-1 loss, sequentially reduced BBB permeability and improved neurological function. Finally, we demonstrated that the salutary effects of miR-103-3p antagomir were abolished in Cav-1 knock-out mice, suggesting that Cav-1 was required for the miR-103-3p inhibition-induced neurovascular protection. Taken together, our findings suggest that the inhibition of miR-103-3p could exert neuroprotective effects through preservation of Cav-1 and BBB integrity, making miR-103-3p a novel therapeutic target for SAH.
Copyright © 2021 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  blood brain barrier; caveolin-1; miR-103-3p; neurovascular dysfunction; subarachnoid hemorrhage

Year:  2021        PMID: 33722672     DOI: 10.1016/j.neuroscience.2021.03.007

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

1.  NBTI attenuates neuroinflammation and apoptosis partly by ENT1/NLRP3/Bcl2 pathway after subarachnoid hemorrhage in rats.

Authors:  Xiaowei Chen; Xiaocheng Luo; Hang Hu; Qianghua Xu
Journal:  Neuroreport       Date:  2021-12-08       Impact factor: 1.837

Review 2.  Non-coding RNAs in the regulation of blood-brain barrier functions in central nervous system disorders.

Authors:  Ping Sun; Milton H Hamblin; Ke-Jie Yin
Journal:  Fluids Barriers CNS       Date:  2022-03-26

Review 3.  Noncoding RNA as Diagnostic and Prognostic Biomarkers in Cerebrovascular Disease.

Authors:  Ruiyuan Weng; Zhiwen Jiang; Yuxiang Gu
Journal:  Oxid Med Cell Longev       Date:  2022-04-19       Impact factor: 7.310

Review 4.  Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease.

Authors:  Shilu Luo; Ming Yang; Hao Zhao; Yachun Han; Na Jiang; Jinfei Yang; Wei Chen; Chenrui Li; Yan Liu; Chanyue Zhao; Lin Sun
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.